High Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy.

Published in: Therapeutics and clinical risk management (2021)

The results of the current retrospective analysis provided a robust and independent adverse prognostic value for pretreatment PAR ≥ 5.2 in terms of median and long-term PFS and OS outcomes in LA-NPC patients this patient group treated with conclusive CCRT.

Keyphrases

locally advanced
newly diagnosed
rectal cancer
end stage renal disease
ejection fraction
squamous cell carcinoma
neoadjuvant chemotherapy
prognostic factors
case report
emergency department
radiation therapy
clinical trial
type diabetes
patient reported outcomes
lymph node
open label
placebo controlled